DEA Schedules Two Potent Synthetic Opioids in Strictest Ban Category
Published Date: 12/23/2025
Rule
Summary
Starting January 22, 2026, two powerful drugs called N-desethyl isotonitazene and N-piperidinyl etonitazene will be officially banned and placed in the toughest drug category, Schedule I. This means anyone making, selling, or using these drugs will face serious legal trouble. This move helps the U.S. follow international drug rules and keeps communities safer without adding new costs.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 3 costs, 0 mixed.
Manufacturers and Distributors Face Schedule I Controls
Starting January 22, 2026, manufacturers, distributors, importers, and exporters of N-desethyl isotonitazene and N-piperidinyl etonitazene must be registered with the DEA and follow Schedule I rules. That includes following 21 U.S.C. registration and quota rules, keeping inventories (initial inventory and new inventories every two years), meeting security and labeling rules, submitting reports to the Automation of Reports and Consolidated Order System, and obeying order-form, import/export, and disposal rules; violations may bring administrative, civil, or criminal penalties.
Researchers and Instructional Users Must Register
From January 22, 2026, anyone who engages in research or instructional activities with these two substances must register with DEA and follow Schedule I requirements such as security screening, labeling and packaging rules, disposal under 21 CFR part 1317, and recordkeeping and reporting obligations. All research or instructional use is subject to the same inventory, security, and reporting rules that apply to Schedule I controlled substances.
Possession or Retail Sales Will Be Unlawful
Effective January 22, 2026, possession of any quantity of N-desethyl isotonitazene or N-piperidinyl etonitazene without DEA authorization is unlawful and may lead to prosecution, and retail sales of Schedule I substances to the general public are not allowed under the Controlled Substances Act. Unauthorized activities involving these substances may result in administrative, civil, and criminal sanctions.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20226, By Grace Inc. Counseling Services; Decision and Order
By Grace Inc. Counseling Services in Baltimore faced losing its DEA license because it didn’t keep good records and lied about its owner’s past drug conviction. After a hearing, the DEA decided to revoke their registration, meaning they can’t legally handle controlled substances anymore. This affects the clinic’s ability to operate and could impact patients relying on their services.
2026-20227, St. Michael's Pharmacy; Decision and Order
St. Michael's Pharmacy in Texas had its DEA license suspended and is facing revocation because it kept filling risky drug prescriptions without fixing obvious warning signs of abuse. This affects the pharmacy’s ability to legally handle controlled substances and could impact patients relying on it. The pharmacy must now deal with these serious legal actions, which started in late 2025 and could lead to permanent closure or fines.
Previous / Next Documents
Previous: 2025-23685, Safety Zone; West of Cyril E. King Airport, St. Thomas, VI
Starting January 1, 2026, the Coast Guard is setting up a temporary safety zone in the waters west of Cyril E. King Airport in St. Thomas to keep boats and people safe from low-flying planes. No one can enter this zone without special permission until March 31, 2026. This rule helps prevent accidents and protects the environment, with no extra costs for the public.
Next: 2025-23738, Amendment of Colored Federal Airway Green 8, Jet Route J-115, United States Area Navigation (RNAV) Route T-227 and Establishment of RNAV Route Q-188 in Alaska; Correction
The FAA fixed some mix-ups in their recent Alaska flight route updates involving Green 8, Jet Route J-115, and RNAV Route T-227, plus the new RNAV Route Q-188. These changes help pilots navigate better after the Shemya radio beacon is retired. The corrected rules kick in January 22, 2026, with no extra costs for airlines or travelers.